Gemin X Pharmaceuticals Inc — Form D
Gemin X Pharmaceuticals Inc of Montreal, A8, a company, filed a Form D exempt-offering notice with the SEC on 2009-06-12. The offering totals $20.0M, of which $9.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-06-12
- Form: D
- Accession: 0001407168-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $20.0M
- Amount sold: $9.3M
- Remaining: $10.7M
- Investors: 24
- Date of first sale: 2009-05-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-106175
Issuer
- Name: Gemin X Pharmaceuticals Inc
- CIK: 0001407168
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 3576 AVENUE DU PARC, Montreal, A8, H2X 2H7
- Phone: 514-281-8989
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Aaron Davidson | Director | Toronto, A6 |
| Robert Gorman | Director | NORTHBROOK, IL |
| Jean Viallet | Executive Officer | Montreal, A8 |
| Eric W Roberts | Director | La Jolla, CA |
| Timothy J Barberich | Director | Woburn, MA |
| Robert G McNeil | Director | La Jolla, CA |
| D. Michael Dixon | Executive Officer | Montreal, A8 |
| ANDREW R JORDAN | Director | LEWISVILLE, TX |
| Gordon C Shore | Director | Montreal, A8 |
| Gordon C Shore | Executive Officer | Montreal, A8 |
| Robert J Gorman | Director | Malvern, PA |
| Scott J Morenstein | Director | Malvern, PA |
| Jean Michael Viallet | Executive Officer | Malvern, PA |
| Peter R Dolan | Director | Malvern, PA |
| Peter R Dolan | Executive Officer | Malvern, PA |
Other filings by this issuer (1)
More